Pfizer Expects To Seek US Approval For COVID-19 Vaccine For Children Aged 6 Months To 5 Years In November

Pfizer Inc expects to apply for U.S. authorization of its COVID-19 vaccine for children aged six months and five years in November, the Financial Times reported.
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.